{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T20:05:15Z","timestamp":1743797115955,"version":"3.37.3"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T00:00:00Z","timestamp":1653436800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T00:00:00Z","timestamp":1653436800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orthop\u00e4die"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1007\/s00132-022-04260-7","type":"journal-article","created":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T08:03:38Z","timestamp":1653465818000},"page":"595-606","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Osteogenesis imperfecta"],"prefix":"10.1007","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8533-2164","authenticated-orcid":false,"given":"Gabriel T.","family":"Mindler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rudolf","family":"Ganger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra","family":"Stauffer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Marhofer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adalbert","family":"Raimann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,5,25]]},"reference":[{"key":"4260_CR1","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1016\/S0140-6736(04)16051-0","volume":"363","author":"F Rauch","year":"2004","unstructured":"Rauch\u00a0F, Glorieux\u00a0FH (2004) Osteogenesis imperfecta. Lancet 363:1377\u20131385. https:\/\/doi.org\/10.1016\/S0140-6736(04)16051-0","journal-title":"Lancet"},{"key":"4260_CR2","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1002\/ajmg.a.36545","volume":"164","author":"F Van Dijk","year":"2014","unstructured":"Van Dijk\u00a0F, Sillence\u00a0D (2014) Osteogenesis imperfecta: clinical diagnosis, nomenclature and severity assessment. Am J Med Genet\u00a0A 164:1470\u20131481. https:\/\/doi.org\/10.1002\/ajmg.a.36545","journal-title":"Am J Med Genet A"},{"key":"4260_CR3","doi-asserted-by":"publisher","first-page":"100734","DOI":"10.1016\/j.bonr.2020.100734","volume":"14","author":"F Shapiro","year":"2021","unstructured":"Shapiro\u00a0F, Maguire\u00a0K, Swami\u00a0S et\u00a0al (2021) Histopathology of osteogenesis imperfecta bone. Supramolecular assessment of cells and matrices in the context of woven and lamellar bone formation using light, polarization and ultrastructural microscopy. Bone Rep 14:100734. https:\/\/doi.org\/10.1016\/j.bonr.2020.100734","journal-title":"Bone Rep"},{"key":"4260_CR4","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s00112-016-0189-5","volume":"165","author":"H Hoyer-Kuhn","year":"2017","unstructured":"Hoyer-Kuhn\u00a0H, Bartz-Seel\u00a0J, Blickheuser\u00a0R et al (2017) Diagnostik und Therapie der Osteogenesis imperfecta. Diagnostics and treatment of osteogenesis imperfecta. Monatsschr Kinderheilkd 165:333\u2013346. https:\/\/doi.org\/10.1007\/s00112-016-0189-5","journal-title":"Monatsschr Kinderheilkd"},{"key":"4260_CR5","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s41969-020-00120-x","volume":"13","author":"A Raimann","year":"2020","unstructured":"Raimann\u00a0A, Haeusler\u00a0G (2020) Osteoporose im Kindes- und Jugendalter. J\u00a0Klin Endokrinol Stoffwechs 13:163\u2013171. https:\/\/doi.org\/10.1007\/s41969-020-00120-x","journal-title":"J Klin Endokrinol Stoffwechs"},{"key":"4260_CR6","doi-asserted-by":"publisher","first-page":"R185","DOI":"10.1530\/EJE-14-0865","volume":"173","author":"V Saraff","year":"2015","unstructured":"Saraff\u00a0V, H\u00f6gler\u00a0W (2015) Osteoporosis in children: diagnosis and management. Eur J Endocrinol 173:R185\u2013R197. https:\/\/doi.org\/10.1530\/EJE-14-0865","journal-title":"Eur J Endocrinol"},{"key":"4260_CR7","volume-title":"ISCD official positions\u2014pediatric","author":"International Society for Clinical Densitometry","year":"2019","unstructured":"International Society for Clinical Densitometry (2019) ISCD official positions\u2014pediatric"},{"key":"4260_CR8","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1002\/ajmg.c.31463","volume":"169","author":"EM Pereira","year":"2015","unstructured":"Pereira\u00a0EM (2015) Clinical perspectives on osteogenesis imperfecta versus non-accidental injury. Am J Med Genet C Semin Med Genet 169:302\u2013306. https:\/\/doi.org\/10.1002\/ajmg.c.31463","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"4260_CR9","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1136\/jmg.16.2.101","volume":"16","author":"DO Sillence","year":"1979","unstructured":"Sillence\u00a0DO, Senn\u00a0A, Danks\u00a0DM (1979) Genetic heterogeneity in osteogenesis imperfecta. J\u00a0Med Genet 16:101\u2013116. https:\/\/doi.org\/10.1136\/jmg.16.2.101","journal-title":"J Med Genet"},{"key":"4260_CR10","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.earlhumdev.2018.08.014","volume":"126","author":"SA Borg","year":"2018","unstructured":"Borg\u00a0SA, Bishop\u00a0NJ (2018) New diagnostic modalities and emerging treatments for neonatal bone disease. Early Hum Dev 126:32\u201337. https:\/\/doi.org\/10.1016\/j.earlhumdev.2018.08.014","journal-title":"Early Hum Dev"},{"key":"4260_CR11","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.jocd.2014.01.003","volume":"17","author":"NJ Crabtree","year":"2014","unstructured":"Crabtree\u00a0NJ, Arabi\u00a0A, Bachrach\u00a0LK et al (2014) Dual-energy X\u2011ray absorptiometry interpretation and reporting in children and adolescents: the revised 2013 ISCD pediatric official positions. J\u00a0Clin Densitom 17:225\u2013242. https:\/\/doi.org\/10.1016\/j.jocd.2014.01.003","journal-title":"J Clin Densitom"},{"key":"4260_CR12","first-page":"445","volume":"14","author":"H Hoyer-Kuhn","year":"2014","unstructured":"Hoyer-Kuhn\u00a0H, Semler\u00a0O, Stark\u00a0C et al (2014) A specialized rehabilitation approach improves mobility in children with osteogenesis imperfecta. J\u00a0Musculoskelet Neuronal Interact 14:445\u2013453","journal-title":"J Musculoskelet Neuronal Interact"},{"key":"4260_CR13","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1186\/s13023-018-0905-4","volume":"13","author":"B Mueller","year":"2018","unstructured":"Mueller\u00a0B, Engelbert\u00a0R, Baratta-Ziska\u00a0F et al (2018) Consensus statement on physical rehabilitation in children and adolescents with osteogenesis imperfecta. Orphanet J Rare Dis 13:158. https:\/\/doi.org\/10.1186\/s13023-018-0905-4","journal-title":"Orphanet J Rare Dis"},{"key":"4260_CR14","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1080\/17453674.2021.1941628","volume":"92","author":"RJ Sakkers","year":"2021","unstructured":"Sakkers\u00a0RJ, Montpetit\u00a0K, Tsimicalis\u00a0A et\u00a0al (2021) A roadmap to surgery in osteogenesis imperfecta: results of an international collaboration of patient organizations and interdisciplinary care teams. Acta Orthop 92:608\u2013614. https:\/\/doi.org\/10.1080\/17453674.2021.1941628","journal-title":"Acta Orthop"},{"key":"4260_CR15","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/s11914-017-0401-0","volume":"15","author":"A Biggin","year":"2017","unstructured":"Biggin\u00a0A, Munns\u00a0CF (2017) Long-term bisphosphonate therapy in osteogenesis imperfecta. Curr Osteoporos Rep 15:412\u2013418. https:\/\/doi.org\/10.1007\/s11914-017-0401-0","journal-title":"Curr Osteoporos Rep"},{"key":"4260_CR16","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1186\/s12891-018-2252-y","volume":"19","author":"MD Garganta","year":"2018","unstructured":"Garganta\u00a0MD, Jaser\u00a0SS, Lazow\u00a0MA et\u00a0al (2018) Cyclic bisphosphonate therapy reduces pain and improves physical functioning in children with osteogenesis imperfecta. BMC Musculoskelet Disord 19:344. https:\/\/doi.org\/10.1186\/s12891-018-2252-y","journal-title":"BMC Musculoskelet Disord"},{"key":"4260_CR17","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1016\/s0278-2391(03)00720-1","volume":"61","author":"RE Marx","year":"2003","unstructured":"Marx\u00a0RE (2003) Pamidronate (aredia) and zoledronate (zometa) induced avascular necrosis of the jaws: a growing epidemic. J\u00a0Oral Maxillofac Surg 61:1115\u20131117. https:\/\/doi.org\/10.1016\/s0278-2391(03)00720-1","journal-title":"J. Oral. Maxillofac. Surg."},{"key":"4260_CR18","doi-asserted-by":"publisher","DOI":"10.4414\/smw.2016.14322","author":"B Bregou","year":"2016","unstructured":"Bregou\u00a0B, Aubry-Rozier\u00a0B, Bonaf\u00e9\u00a0L et al (2016) Osteogenesis imperfecta: from diagnosis and multidisciplinary treatment to future perspectives. Swiss Med Wkly. https:\/\/doi.org\/10.4414\/smw.2016.14322","journal-title":"Swiss Med Wkly"},{"key":"4260_CR19","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1007\/s00132-006-1037-4","volume":"36","author":"O Semler","year":"2012","unstructured":"Semler\u00a0O, Land\u00a0C, Sch\u00f6nau\u00a0E (2012) Bisphosphonat-Therapie bei Kindern und Jugendlichen mit prim\u00e4ren und sekund\u00e4ren osteoporotischen Erkrankungen. Orthop\u00e4de 36:146\u2013151. https:\/\/doi.org\/10.1007\/s00132-006-1037-4","journal-title":"Orthop\u00e4de"},{"key":"4260_CR20","volume-title":"An open-label, ascending multiple-dose study to evaluate safety, tolerability, pharmacokinetics, and pharmacodynamics of romosozumab in children and adolescents with osteogenesis Imperfecta","author":"Amgen","year":"2022","unstructured":"Amgen (2022) An open-label, ascending multiple-dose study to evaluate safety, tolerability, pharmacokinetics, and pharmacodynamics of romosozumab in children and adolescents with osteogenesis Imperfecta (clinicaltrials.gov)"},{"key":"4260_CR21","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1359\/jbmr.2003.18.2.237","volume":"18","author":"JC Marini","year":"2003","unstructured":"Marini\u00a0JC, Hopkins\u00a0E, Glorieux\u00a0FH et\u00a0al (2003) Positive linear growth and bone responses to growth hormone treatment in children with types III and IV osteogenesis imperfecta: high predictive value of the carboxyterminal propeptide of type I procollagen. J\u00a0Bone Miner Res 18:237\u2013243. https:\/\/doi.org\/10.1359\/jbmr.2003.18.2.237","journal-title":"J Bone Miner Res"},{"key":"4260_CR22","doi-asserted-by":"publisher","first-page":"153","DOI":"10.11138\/ccmbm\/2017.14.1.153","volume":"14","author":"PT Leali","year":"2017","unstructured":"Leali\u00a0PT, Balsano\u00a0M, Maestretti\u00a0G et\u00a0al (2017) Efficacy of teriparatide vs neridronate in adults with osteogenesis imperfecta type I: a prospective randomized international clinical study. Clin Cases Miner Bone Metab 14:153\u2013156. https:\/\/doi.org\/10.11138\/ccmbm\/2017.14.1.153","journal-title":"Clin Cases Miner Bone Metab"},{"key":"4260_CR23","volume-title":"An exploratory, open label, multiple dose, multicentre phase I\/II trial evaluating safety and efficacy of postnatal or prenatal and postnatal intravenous administration of allogeneic expanded fetal mesenchymal stem cells","author":"C G\u00f6therstr\u00f6m","year":"2021","unstructured":"G\u00f6therstr\u00f6m\u00a0C (2021) An exploratory, open label, multiple dose, multicentre phase I\/II trial evaluating safety and efficacy of postnatal or prenatal and postnatal intravenous administration of allogeneic expanded fetal mesenchymal stem cells (for the treatment of severe osteogenesis imperfecta compared with a combination of historical and untreated prospective controls)"},{"key":"4260_CR24","doi-asserted-by":"publisher","first-page":"2734","DOI":"10.1210\/jc.2017-00275","volume":"102","author":"W H\u00f6gler","year":"2017","unstructured":"H\u00f6gler\u00a0W, Scott\u00a0J, Bishop\u00a0N et\u00a0al (2017) The effect of whole body vibration training on bone and muscle function in children with osteogenesis imperfecta. J\u00a0Clin Endocrinol Metab 102:2734\u20132743. https:\/\/doi.org\/10.1210\/jc.2017-00275","journal-title":"J Clin Endocrinol Metab"},{"key":"4260_CR25","doi-asserted-by":"publisher","first-page":"4260","DOI":"10.1210\/jc.2017-01514","volume":"102","author":"H Hoyer-Kuhn","year":"2017","unstructured":"Hoyer-Kuhn\u00a0H, Schoenau\u00a0E, Semler\u00a0O (2017) Letter to the editor: \u201cthe effect of whole body vibration training on bone and muscle function in children with osteogenesis imperfecta\u201d. J\u00a0Clin Endocrinol Metab 102:4260\u20134261. https:\/\/doi.org\/10.1210\/jc.2017-01514","journal-title":"J Clin Endocrinol Metab"},{"key":"4260_CR26","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/s11914-020-00608-0","volume":"18","author":"D Swolin-Eide","year":"2020","unstructured":"Swolin-Eide\u00a0D, Magnusson\u00a0P (2020) Does whole-body vibration treatment make children\u2019s bones stronger? Curr Osteoporos Rep 18:471\u2013479. https:\/\/doi.org\/10.1007\/s11914-020-00608-0","journal-title":"Curr Osteoporos Rep"},{"key":"4260_CR27","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1080\/24740527.2017.1422115","volume":"2","author":"T Nghiem","year":"2018","unstructured":"Nghiem\u00a0T, Chougui\u00a0K, Michalovic\u00a0A et\u00a0al (2018) Pain experiences of adults with osteogenesis imperfecta: an integrative review. Can J Pain 2:9\u201320. https:\/\/doi.org\/10.1080\/24740527.2017.1422115","journal-title":"Can J Pain"},{"key":"4260_CR28","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1097\/BPO.0000000000000824","volume":"38","author":"KA Azzam","year":"2018","unstructured":"Azzam\u00a0KA, Rush\u00a0ET, Burke\u00a0BR et al (2018) Mid-term results of femoral and tibial osteotomies and Fassier-Duval nailing in children with osteogenesis imperfecta. J\u00a0Pediatr Orthop 38:331\u2013336. https:\/\/doi.org\/10.1097\/BPO.0000000000000824","journal-title":"J Pediatr Orthop"},{"key":"4260_CR29","doi-asserted-by":"publisher","first-page":"417","DOI":"10.4055\/cios20060","volume":"12","author":"T-J Cho","year":"2020","unstructured":"Cho\u00a0T\u2011J, Ko\u00a0JM, Kim\u00a0H et al (2020) Management of osteogenesis imperfecta: a multidisciplinary comprehensive approach. Clin Orthop Surg 12:417\u2013429. https:\/\/doi.org\/10.4055\/cios20060","journal-title":"Clin Orthop Surg"},{"key":"4260_CR30","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1007\/s11914-021-00665-z","volume":"19","author":"FR Fassier","year":"2021","unstructured":"Fassier\u00a0FR (2021) Osteogenesis imperfecta-who needs rodding surgery? Curr Osteoporos Rep 19:264\u2013270. https:\/\/doi.org\/10.1007\/s11914-021-00665-z","journal-title":"Curr Osteoporos Rep"},{"key":"4260_CR31","doi-asserted-by":"publisher","first-page":"e347","DOI":"10.1097\/BPO.0000000000001763","volume":"41","author":"BJ Musielak","year":"2021","unstructured":"Musielak\u00a0BJ, Wo\u017aniak \u0141, Su\u0142ko\u00a0J et al (2021) Problems, complications, and factors predisposing to failure of Fassier-Duval rodding in children with osteogenesis imperfecta: a double-center study. J\u00a0Pediatr Orthop 41:e347\u2013e352. https:\/\/doi.org\/10.1097\/BPO.0000000000001763","journal-title":"J Pediatr Orthop"},{"key":"4260_CR32","doi-asserted-by":"publisher","DOI":"10.1097\/BPO.0000000000002040","author":"B Yong","year":"2022","unstructured":"Yong\u00a0B, De Wouters\u00a0S, Howard\u00a0A (2022) Complications of elongating intramedullary rods in the treatment of lower extremity fractures for osteogenesis imperfecta: a meta-analysis of 594 patients in 40 years. J\u00a0Pediatr Orthop. https:\/\/doi.org\/10.1097\/BPO.0000000000002040","journal-title":"J Pediatr Orthop"},{"key":"4260_CR33","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1097\/BPO.0000000000001883","volume":"41","author":"KV Suresh","year":"2021","unstructured":"Suresh\u00a0KV, Vankara\u00a0A, Lentz\u00a0JM, Sponseller\u00a0PD (2021) Interlocking fixation in Fassier-Duval rods: performance and success factors. J\u00a0Pediatr Orthop 41:525\u2013529. https:\/\/doi.org\/10.1097\/BPO.0000000000001883","journal-title":"J Pediatr Orthop"},{"key":"4260_CR34","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1097\/01202412-200509000-00001","volume":"14","author":"B Joseph","year":"2005","unstructured":"Joseph\u00a0B, Rebello\u00a0G, Chandra Kant\u00a0B (2005) The choice of intramedullary devices for the femur and the tibia in osteogenesis imperfecta. J\u00a0Pediatr Orthop\u00a0B 14:311\u2013319","journal-title":"J Pediatr Orthop B"},{"key":"4260_CR35","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1186\/s13023-018-0935-y","volume":"13","author":"M Najirad","year":"2018","unstructured":"Najirad\u00a0M, Ma\u00a0MS, Rauch\u00a0F et al (2018) Oral health-related quality of life in children and adolescents with osteogenesis imperfecta: cross-sectional study. Orphanet J Rare Dis 13:187. https:\/\/doi.org\/10.1186\/s13023-018-0935-y","journal-title":"Orphanet J Rare Dis"},{"key":"4260_CR36","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.hlc.2013.05.640","volume":"22","author":"A Lamanna","year":"2013","unstructured":"Lamanna\u00a0A, Fayers\u00a0T, Clarke\u00a0S, Parsonage\u00a0W (2013) Valvular and aortic diseases in osteogenesis imperfecta. Heart Lung Circ 22:801\u2013810. https:\/\/doi.org\/10.1016\/j.hlc.2013.05.640","journal-title":"Heart Lung Circ"},{"key":"4260_CR37","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1186\/s13023-021-02058-y","volume":"16","author":"A LoMauro","year":"2021","unstructured":"LoMauro\u00a0A, Landoni\u00a0CV, Fraschini\u00a0P et\u00a0al (2021) Eat, breathe, sleep with osteogenesis imperfecta. Orphanet J Rare Dis 16:435. https:\/\/doi.org\/10.1186\/s13023-021-02058-y","journal-title":"Orphanet J Rare Dis"},{"key":"4260_CR38","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.pedhc.2018.12.003","volume":"33","author":"MA Lazow","year":"2019","unstructured":"Lazow\u00a0MA, Jaser\u00a0SS, Cobry\u00a0EC et\u00a0al (2019) Stress, depression, and quality of life among caregivers of children with osteogenesis imperfecta. J\u00a0Pediatr Health Care 33:437\u2013445. https:\/\/doi.org\/10.1016\/j.pedhc.2018.12.003","journal-title":"J Pediatr Health Care"},{"key":"4260_CR39","unstructured":"Wosart Self portaiture. https:\/\/www.wosart.com\/self-portaiture\/. Zugegriffen: 4. Febr. 2022"},{"key":"4260_CR40","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1111\/pan.13504","volume":"28","author":"L Rothschild","year":"2018","unstructured":"Rothschild\u00a0L, Goeller\u00a0JK, Voronov\u00a0P et\u00a0al (2018) Anesthesia in children with osteogenesis imperfecta: retrospective chart review of 83 patients and 205 anesthetics over 7 years. Paediatr Anaesth 28:1050\u20131058. https:\/\/doi.org\/10.1111\/pan.13504","journal-title":"Paediatr Anaesth"},{"key":"4260_CR41","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1093\/bja\/aei002","volume":"94","author":"P Marhofer","year":"2005","unstructured":"Marhofer\u00a0P, Greher\u00a0M, Kapral\u00a0S (2005) Ultrasound guidance in regional anaesthesia. Br J Anaesth 94:7\u201317. https:\/\/doi.org\/10.1093\/bja\/aei002","journal-title":"Br J Anaesth"},{"key":"4260_CR42","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1093\/bja\/aem092","volume":"98","author":"U Oberndorfer","year":"2007","unstructured":"Oberndorfer\u00a0U, Marhofer\u00a0P, B\u00f6senberg\u00a0A et\u00a0al (2007) Ultrasonographic guidance for sciatic and femoral nerve blocks in children. Br J Anaesth 98:797\u2013801. https:\/\/doi.org\/10.1093\/bja\/aem092","journal-title":"Br J Anaesth"},{"key":"4260_CR43","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.bja.2020.03.012","volume":"125","author":"M Zadrazil","year":"2020","unstructured":"Zadrazil\u00a0M, Opfermann\u00a0P, Marhofer\u00a0P et al (2020) Brachial plexus block with ultrasound guidance for upper-limb trauma surgery in children: a retrospective cohort study of 565 cases. Br J Anaesth 125:104\u2013109. https:\/\/doi.org\/10.1016\/j.bja.2020.03.012","journal-title":"Br J Anaesth"},{"key":"4260_CR44","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.bja.2018.11.030","volume":"122","author":"M Wiegele","year":"2019","unstructured":"Wiegele\u00a0M, Marhofer\u00a0P, L\u00f6nnqvist\u00a0P\u2011A (2019) Caudal epidural blocks in paediatric patients: a review and practical considerations. Br J Anaesth 122:509\u2013517. https:\/\/doi.org\/10.1016\/j.bja.2018.11.030","journal-title":"Br J Anaesth"},{"key":"4260_CR45","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1111\/pan.12972","volume":"26","author":"M Keplinger","year":"2016","unstructured":"Keplinger\u00a0M, Marhofer\u00a0P, Klug\u00a0W et\u00a0al (2016) Feasibility and pharmacokinetics of caudal blockade in children and adolescents with 30\u201350 kg of body weight. Paediatr Anaesth 26:1053\u20131059. https:\/\/doi.org\/10.1111\/pan.12972","journal-title":"Paediatr Anaesth"}],"container-title":["Die Orthop\u00e4die"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00132-022-04260-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00132-022-04260-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00132-022-04260-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T08:03:40Z","timestamp":1656662620000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00132-022-04260-7"}},"subtitle":["Eine multidisziplin\u00e4re Herausforderung","A\u00a0multidisciplinary challenge"],"short-title":[],"issued":{"date-parts":[[2022,5,25]]},"references-count":45,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["4260"],"URL":"https:\/\/doi.org\/10.1007\/s00132-022-04260-7","relation":{},"ISSN":["2731-7145","2731-7153"],"issn-type":[{"type":"print","value":"2731-7145"},{"type":"electronic","value":"2731-7153"}],"subject":[],"published":{"date-parts":[[2022,5,25]]},"assertion":[{"value":"11 April 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"Gem\u00e4\u00df den Richtlinien des Springer Medizin Verlags werden Autoren und Wissenschaftliche Leitung im Rahmen der Manuskripterstellung und Manuskriptfreigabe aufgefordert, eine vollst\u00e4ndige Erkl\u00e4rung zu ihren finanziellen und nichtfinanziellen Interessen abzugeben.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"<b>G.T.\u00a0Mindler<\/b>: A.\u00a0Finanzielle Interessen: Nicht assoziierte Vortragst\u00e4tigkeit Kyowa Kirin Vortragst\u00e4tigkeit 2021 (Thema: Phosphatdiabetes). Nicht assoziierte Beratert\u00e4tigkeit Biomarin (Thema: Achondroplasie) \u2013\u00a0B.\u00a0Nichtfinanzielle Interessen: Abteilung f\u00fcr Kinderorthop\u00e4die und Fu\u00dfchirurgie (Oberarzt), Orthop\u00e4disches Spital Speising, Vienna Bone and Growth Center, Privatordination\u00a0| Mitgliedschaften: \u00d6GO (\u00d6sterreichische Gesellschaft f\u00fcr Orthop\u00e4die), \u00d6GU (\u00d6sterreichische Gesellschaft f\u00fcr Unfallchirurgie), ECTS (European Calcified Tissue Society), GAMMA (Gesellschaft f\u00fcr die Analyse Menschlicher Motorik und ihre klinische Anwendung), VKO (Vereinigung f\u00fcr Kinderorthop\u00e4die), EPOS (European Paediatric Orthopaedic Society). <b>R.\u00a0Ganger<\/b>: A.\u00a0Finanzielle Interessen: Honorar Leitung Symposium\u00a0\u2013 NuVasive Inc. \u2013\u00a0Schulungsreferent OP-Training\u00a0\u2013 NuVasive Inc Smith\u00a0&\u00a0Nephew Europe. \u2013\u00a0B.\u00a0Nichtfinanzielle Interessen: Abteilung f\u00fcr Kinderorthop\u00e4die und Fu\u00dfchirurgie (Abteilungsleiter), Orthop\u00e4disches Spital Speising, Privatordination, Facharzt f\u00fcr Orthop\u00e4die; Vienna Bone and Growth Center\u00a0\u2013 Co-Administrator\u00a0| Mitgliedschaften: VKO, EPOS, \u00d6GO, \u00d6GOuT. <b>A.\u00a0Stauffer<\/b>: A.\u00a0Finanzielle Interessen: A.\u00a0Stauffer gibt an, dass kein finanzieller Interessenkonflikt besteht. \u2013\u00a0B.\u00a0Nichtfinanzielle Interessen: \u00c4rztin in Ausbildung zur Fach\u00e4rztin f\u00fcr Orthop\u00e4die und Traumatologie im Orthop\u00e4dischen Spital Speising, derzeit auf Rotation im Traumazentrum Wien\u00a0\u2013 Standort Meidling\u00a0| Mitgliedschaft: \u00d6sterreichische Gesellschaft f\u00fcr Unfallchirurgie (\u00d6GU). <b>P.\u00a0Marhofer<\/b>: A.\u00a0Finanzielle Interessen: Forschungsf\u00f6rderung zur pers\u00f6nlichen Verf\u00fcgung: Primex \u2013\u00a0unrestricted grant (20.000\u202f\u20ac).\u00a0\u2013 Safer Sonic Inc. \u2013\u00a0Travel reimbursement.\u00a0\u2013 BD Advisory Board regional anaesthesia. \u2013\u00a0B.\u00a0Nichtfinanzielle Interessen: Abteilung f\u00fcr An\u00e4sthesiologie und Intensivmedizin (Abteilungsleiter)\u00a0| Mitgliedschaften: \u00d6GARI (\u00d6sterreichische Gesellschaft f\u00fcr An\u00e4sthesiologie, Reanimation und Intensivmedizin), ESRA (The European Society of regional anaesthesia & Pain therapy). <b>A.\u00a0Raimann<\/b>: A.\u00a0Finanzielle Interessen: Nicht assoziierte Forschungsf\u00f6rderung Kyowa Kirin.\u00a0\u2013 Nicht assoziierte Vortragst\u00e4tigkeit Kyowa Kirin, Ipsen Pharma, nicht assoziierte Reisekostenerstattung Ipsen Pharma, Pfizer, ECTS. \u2013\u00a0Nicht assoziierte Beratert\u00e4tigkeit Kyowa Kirin, nicht assoziiertes Honorar (Preisgeld) Ferring.\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: Angestellte Kinderfacharzt, MedUniWien, Wien, niedergelassener Facharzt f\u00fcr Kinder- und Jugendheilkunde, Wien\u00a0| Mitgliedschaften ECTS, ESPE, ICCBH, APED\u00d6, \u00d6GKJ, \u00d6GES, Steering Committe APED\u00d6, Programm Organizing Committee ESPE.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Autoren"}},{"value":"Die vollst\u00e4ndige Erkl\u00e4rung zum Interessenkonflikt der Wissenschaftlichen Leitung finden Sie am Kurs der zertifizierten Fortbildung auf .","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Wissenschaftliche Leitung"}},{"value":"erkl\u00e4rt, dass f\u00fcr die Publikation dieser CME-Fortbildung keine Sponsorengelder an den Verlag flie\u00dfen.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien. F\u00fcr Bildmaterial oder anderweitige Angaben innerhalb des Manuskripts, \u00fcber die Patienten zu identifizieren sind, liegt von ihnen und\/oder ihren gesetzlichen Vertretern eine schriftliche Einwilligung vor.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}}]}}